Menu Close

Stem cell therapy is the use of stem cells to treat or stop a ailment or problem

Stem cell treatment is the use of stem cells to treat or prevent a ailment or problem. Bone marrow transplant is the most extensively employed stem-cell treatment, but some therapies derived from umbilical cord blood are also in use. Study is underway to develop numerous sources for stem cells, as well as to apply stem-cell treatments for neurodegenerative illnesses and circumstances this kind of as diabetes and heart ailment, among others.

Stem-cell treatment has turn into controversial following developments this kind of as the capability of scientists to isolate and culture embryonic stem cells, to create stem cells utilizing somatic cell nuclear transfer and their use of methods to create induced pluripotent stem cells. This controversy is usually related to abortion politics and to human cloning. In addition, efforts to market place treatments based on transplant of stored umbilical cord blood have been controversial.

For above thirty years, bone marrow has been used to treat individuals with cancer with circumstances this kind of as leukaemia and lymphoma this is the only kind of stem-cell treatment that is extensively practiced. Throughout chemotherapy, most growing cells are killed by the cytotoxic agents. These agents, nevertheless, can’t discriminate in between the leukaemia or neoplastic cells, and the hematopoietic stem cells inside the bone marrow. It is this side effect of typical chemotherapy strategies that the stem-cell transplant attempts to reverse a donor’s healthy bone marrow reintroduces practical stem cells to replace the cells misplaced in the host’s entire body in the course of treatment method. The transplanted cells also make an immune response that assists to kill off the cancer cells this approach can go too far, nevertheless, top to graft vs host ailment, the most critical side effect of this treatment method.

An additional stem cell treatment called Prochymal, was conditionally approved in Canada in 2012 for the management of acute graft-vs-host ailment in children who are unresponsive to steroids. It is an allogenic stem treatment based on mesenchymal stem cells (MSCs) derived from the bone marrow of grownup donors. MSCs are purified from the marrow, cultured and packaged, with up to ten,000 doses derived from a single donor. The doses are stored frozen right up until essential.

The FDA has approved five hematopoietic stem-cell items derived from umbilical cord blood, for the treatment method of blood and immunological illnesses.

In 2014, the European Medicines Company advisable approval of limbal stem cells for individuals with extreme limbal stem cell deficiency due to burns in the eye.